Open Government Portal
Health Canada, working with provinces and territories and other partners, has established a Critical Drug Reserve to help bolster Canadas …
The Interim Order (IO) No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical …
Learn about the outcomes of the public consultations on the COVID-19 clinical trials Interim Order and clinical trials records …
IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to …
This primer is intended to support health care providers in better understanding and addressing COVID-19 vaccine hesitancy, in their …
COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.
We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection …
Simple mathematical modelling approaches to assessing the transmission risk of SARS-CoV-2 at gatherings
Serum antibody response in COVID-19-recovered patients who retested positive
Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario